Pages that link to "Q50984087"

The following pages link to Enhanced memory B-cell immune responses after a second acellular pertussis booster vaccination in children 9 years of age (Q50984087):

Displaying 20 items.

• Waning and aging of cellular immunity to Bordetella pertussis (Q28080731) (← links)
• Pertussis-specific memory B-cell and humoral IgG responses in adolescents after a fifth consecutive dose of acellular pertussis vaccine (Q34260834) (← links)
• Resurgence of pertussis calls for re-evaluation of pertussis animal models (Q34311615) (← links)
• Pertussis circulation has increased T-cell immunity during childhood more than a second acellular booster vaccination in Dutch children 9 years of age. (Q34364307) (← links)
• Differential B-cell memory around the 11-month booster in children vaccinated with a 10- or 13-valent pneumococcal conjugate vaccine (Q35855954) (← links)
• Long-term antibody memory induced by synthetic peptide vaccination is protective against Streptococcus pyogenes infection and is independent of memory T cell help. (Q36675649) (← links)
• Antibody avidity in humoral immune responses in Bangladeshi children and adults following administration of an oral killed cholera vaccine (Q37252387) (← links)
• Age related differences in dynamics of specific memory B cell populations after clinical pertussis infection (Q37472929) (← links)
• Immunity to the respiratory pathogen Bordetella pertussis. (Q38020419) (← links)
• Humoral and B-cell memory responses in children five years after pertussis acellular vaccine priming (Q42227564) (← links)
• Different T cell memory in preadolescents after whole-cell or acellular pertussis vaccination (Q42242318) (← links)
• B-cell responses after intranasal vaccination with the novel attenuated Bordetella pertussis vaccine strain BPZE1 in a randomized phase I clinical trial (Q45233045) (← links)
• Enhanced Bordetella pertussis acquisition rate in adolescents during the 2012 epidemic in the Netherlands and evidence for prolonged antibody persistence after infection. (Q47105091) (← links)
• Whole-cell or acellular pertussis vaccination in infancy determines IgG subclass profiles to DTaP booster vaccination (Q47201970) (← links)
• Whole-Cell or Acellular Pertussis Primary Immunizations in Infancy Determines Adolescent Cellular Immune Profiles (Q48500160) (← links)
• Robust Humoral and Cellular Immune Responses to Pertussis in Adults After a First Acellular Booster Vaccination. (Q52579133) (← links)
• Detection of opsonizing antibodies directed against a recently circulating Bordetella pertussis strain in paired plasma samples from symptomatic and recovered pertussis patients (Q58786827) (← links)
• Differences in avidity of IgG antibodies to pertussis toxin after acellular pertussis booster vaccination and natural infection (Q84976224) (← links)
• Specific memory B cell response in humans upon infection with highly pathogenic H7N7 avian influenza virus (Q89819199) (← links)
• Age-related differences in antibody avidities to pertussis toxin and filamentous hemagglutinin in a healthy Japanese population (Q92727237) (← links)